Ladenburg Thalmann Downgrades NextCure to Neutral

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

Investor Optimism Declines After Dow Tumbles Around 700 Points

The CNN Money Fear and Greed index showed a decline in the overall sentiment among US investors. US stocks dropped sharply on Tuesday amid concerns over higher interest rates. The benchmark 10-year Treasury yield increased to 3.9%, while the 2-year rate rose to 4.7% during the session. The Fed is scheduled to release the minutes from its recent meeting on Wednesday.

BIDU